Union Bancaire Privee, Ubp Sa Ionis Pharmaceuticals Inc Transaction History
Union Bancaire Privee, Ubp Sa
- $4.34 Billion
- Q1 2025
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 265 shares of IONS stock, worth $8,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265
Previous 265
-0.0%
Holding current value
$8,138
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$506 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$435 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$352 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$317 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$242 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.36B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...